10.96
Omeros Corporation Aktie (OMER) Neueste Nachrichten
Omeros Achieves Profitability as Strategic Moves Slash Debt - AD HOC NEWS
Breakout Zone: Is Omeros Corporation impacted by rising rates2026 Summary & Safe Entry Point Identification - baoquankhu1.vn
Omeros (NASDAQ:OMER) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch - tipranks.com
Omeros Q4 2025 earnings preview - MSN
HC Wainwright Brokers Increase Earnings Estimates for Omeros - MarketBeat
Omeros rises as Novo deal boosts Q4 earnings - MSN
Travel Stocks: Can Omeros Corporation withstand a market correctionMarket Volume Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Omeros (NASDAQ:OMER) Shares Down 6.5%Here's Why - MarketBeat
Omeros: Making The Bull Case On Q4 Earnings, Ahead Of Key Q1 Commercial Updates (OMER) - Seeking Alpha
Omeros Corporation (NASDAQ:OMER) Q4 2025 Earnings Call Transcript - Insider Monkey
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Shares Surge on Stellar Earnings and Strategic Progress - AD HOC NEWS
Omeros stock rises after Q4 earnings beat (OMER:NASDAQ) - Seeking Alpha
Omeros Sees Unusually Large Options Volume (NASDAQ:OMER) - MarketBeat
Omeros (NASDAQ:OMER) Shares Gap UpShould You Buy? - MarketBeat
Omeros Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Omeros expects YARTEMLEA to be financially self-sustaining in 2026 and targets positive cash flow in 2027 - MSN
Omeros reports Q4 EPS $1.22, consensus 36c - tipranks.com
Transcript : Omeros Corporation, Q4 2025 Earnings Call, Mar 31, 2026 - marketscreener.com
Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaroun - GuruFocus
Omeros (NASDAQ:OMER) Releases Earnings Results, Beats Estimates By $3.69 EPS - MarketBeat
OMER stock surges 5% after hours on Novo Nordisk deal windfall and drug launch optimism - MSN
Omeros Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Omeros Corporation Reports Q4 and Full-Year 2025 Results - National Today
Omeros Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat By Investing.com - Investing.com South Africa
Earnings call transcript: Omeros Corporation Q4 2025 sees remarkable earnings beat - investing.com
Omeros (OMER) Posts Strong Q4 Results Amid Strategic Advances - gurufocus.com
OMEROS ($OMER) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
Omeros: Q4 Earnings Snapshot - marketscreener.com
Omeros (NASDAQ: OMER) wins TA‑TMA approval and $240M Novo Nordisk pact - Stock Titan
Omeros Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results - The Joplin Globe
BRIEF-Omeros Corporation Q4 EPS USD 1.22 - TradingView
After $240M Novo deal, Omeros launches first approved TA-TMA drug - Stock Titan
Omeros Corporation's Cash Flow Timelines and Formulary Approval Claims Clash in 2025 Earnings Call - Bitget
Omeros Q4 2025 Earnings Call Transcript - MarketBeat
Omeros (NASDAQ:OMER) Share Price Passes Above 200 Day Moving AverageHere's Why - MarketBeat
Aug Sectors: Is Omeros Corporation a play on infrastructure spendingFed Meeting & Reliable Volume Spike Alerts - baoquankhu1.vn
Vanguard entities disaggregate OMER holdings (OMER) after internal realignment - Stock Titan
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 - BioSpace
Omeros Corp Stock: Biotech Innovator Focused on Complement Inhibitors Ahead of Q4 2025 Earnings - AD HOC NEWS
Omeros Corporation (OMER.US) is scheduled to release its earnings report after the market closes on March 31. - 富途牛牛
Sentiment Recap: Can Omeros Corporation withstand a market correctionQuarterly Profit Review & Free Reliable Trade Execution Plans - baoquankhu1.vn
Omeros (OMER) Projected to Post Earnings on Monday - MarketBeat
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment - PharmiWeb.com
GeekWire Awards: Billion-dollar deals, rare IPO, pharma pact, and mega-round vie for Deal of the Year - GeekWire
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):